Skip to search formSkip to main contentSkip to account menu

NSC 329680

Known as: NSC-329680 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

hepsulfam

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Phase I and Pharmacokinetic Study of Hepsulfam ( NSC 329680 ) 1
Hepsulfam (NSC 329680), a bifunctional alkylating agent structurally related to busulfan, has entered clinical trial based on its… 
2006
2006
Hepsulfam , a New Antileukemic Agent , in the L 1210 Cell Line Comparison of the Mechanism of Action of Busulfan with Updated
1,7-1 Irpiatirti ¡ol d¡sull'amati-(hepsulfam, NSC 329680) is a new antileukemic agent with close structural similarity to… 
1995
1995
Hepsulfam distribution in blood, plasma and cerebrospinal fluid of baboons
SummaryThe alkylating agent Hepsulfam (Sulfamic acid 1,7-heptanediyl ester, NSC 329680) was developed as a more hydrophilic… 
1993
1993
In vitro cytotoxicity of hepsulfam against human tumor cell lines and primary human tumor colony forming units
Hepsulfam (sulfamic acid 1,7‐heptanediyl ester, NSC 329680) is an alkylating agent currently in Phase I clinical trials… 
1992
1992
Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.
Hepsulfam (NSC 329680, 1,7-heptanediol disulfamate) is an alkylating agent that showed excellent activity against mouse and human… 
1992
1992
Preclinical activity off hepsulfam and busulfan in solid human tumor xenografts and human bone marrow
Hepsulfam (1,7-heptanediol disulfamate, NSC 329680) is a new antlneoplastic alkanesulfonate agent which has demonstrated a… 
1992
1992
Preclinical activity of hepsulfam and busulfan in solid human tumor xenografts and human bone marrow.
Hepsulfam (1,7-heptanediol disulfamate, NSC 329680) is a new antineoplastic alkanesulfonate agent which has demonstrated a… 
1991
1991
Phase I and pharmacokinetic study of hepsulfam (NSC 329680).
Hepsulfam (NSC 329680), a bifunctional alkylating agent structurally related to busulfan, has entered clinical trial based on its… 
1990
1990
Mechanisms of toxicity of hepsulfam in human tumor cell lines.
1,7-Heptanediol disulfamate (hepsulfam, NSC 329680) is a new anti-cancer agent which is currently undergoing phase I clinical… 
1988
1988
Gas chromatographic assay for the new antitumor agent sulfamic acid diester (NSC 329680) and its stability in buffer, blood and plasma.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)